White-tailed deer found to be huge reservoir of SARS-CoV-2 infection
On Nov. 8, 2020, research from the U.S. had shown that white-tailed deer were being infected with SARS-CoV-2,…
On Nov. 8, 2020, research from the U.S. had shown that white-tailed deer were being infected with SARS-CoV-2,…
On Oct. 9, 2020, OPKO Health subsidiary BioReference Labs, New York City, the Department of Health, New York…
On Oct. 8, 2020, SIGA Technologies announced that the Public Health Agency of Canada (PHAC) has issued an…
On Sept. 8, 2020, the CEOs of AstraZeneca, BioNTech, GlaxoSmithKline, Johnson & Johnson, Merck, Moderna, Novavax, Pfizer, and…
On Sept. 2, 2020, BioReference Laboratories, an OPKO Health company, began testing New York City principals, teachers and…
On Aug. 27, 2020, Todos Medical announced it had entered into a sales agreement with a New York-based…
On Aug. 3, 2020, Bio-Techne and the Mount Sinai Health System in New York, through its commercial affiliate…
On Jul. 29, 2020, Constant Therapeutics announced that its peptide drug TXA127, a pharmaceutical formulation of the natural…
On Jun. 25, 2020, SIGA Technologies announced the deliveries of oral TPOXX (tecovirimat) to the U.S. Department of…
On Jun. 24, 2020, a team of scientists at Texas A&M University announced it is working with iBio…
On Jun. 19, 2020, the COVID-19 pandemic in New York City caused a surge in out-of-hospital cardiac arrests…
On Jun. 18, 2020, researchers at Montefiore Health System and Albert Einstein College of Medicine, in collaboration with…
On Jun. 15, 2020, SIGA Technologies announced the U.S. Department of Defense (DoD) increased research and development funding…
On Jun. 2, 2020, the USDA announced the first confirmed case of SARS-CoV-2 (the virus that causes COVID-19)…
On Jun. 1, 2020, SIGA Technologies announced its first international delivery of TPOXX (tecovirimat), with 2,500 courses delivered…
On May 26, 2020, Montefiore Health System and Albert Einstein College of Medicine began the next stage of…
On May 19, 2020, Bio-Techne and the Mount Sinai Health System in New York, through its commercial affiliate…
On May 8, 2020, BioReference Laboratories, an OPKO Health company, announced the launch of COVID-19 antibody screening available…
On May 7, 2020, a study of nearly 1,400 patients with moderate to severe COVID-19 disease at a…
On Apr. 30, 2020, the research community reacted with alarm and anger to the National Institutes of Health’s…
On Apr. 27, 2020, Atossa Therapeutics announced that it had contracted with NYC Health + Hospitals/Metropolitan in New…
On Apr. 24, 2020, Mesoblast announced an 83% survival in ventilator-dependent COVID-19 patients (10/12) with moderate/severe acute respiratory…
On Apr. 23, 2020, Western New York healthcare and medical research leaders joined forces in an effort to…
On Apr. 22, 2020, the CDC and the USDA National Veterinary Services Laboratories announced the first confirmed cases…
On Apr. 16, 2020, CHF Solutions announced increased utilization of its Aquadex therapy in patients affected by COVID-19….
On Apr. 15, 2020, Vanda Pharma and Northwell Health’s research arm, The Feinstein Institutes for Medical Research, announced…
On Apr. 9, 2020, CytoDyn announced a patient with severe COVID-19 under the care of a leading medical…
On Apr. 6, 2020, IGEA Pharma announced that it was starting to supply of a COVID-19 antibody test…
On Apr. 6, 2020, the USDA confirmed SARS-CoV-2 (the virus that causes COVID-19 in humans) in one tiger…
On Apr. 5, 2020, updated COVID-19 estimates from the Institute for Health Metrics and Evaluation (IHME) found that…